|
HS Code |
416349 |
| Chemical Name | (2S-Cis)-2-[(Dimethylamino)Carbonyl]-4-Mercapto-1-Pyrrolidinecarboxylic Acid, (4-Nitrophenyl) Methyl Ester |
As an accredited (2S-Cis)-2-[(Dimethylamino)Carbonyl]-4-Mercapto-1-Pyrrolidinecarboxylic Acid, (4-Nitrophenyl) Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 10 - gram vial of (2S - Cis)-2-[(Dimethylamino)Carbonyl]-4 - Mercapto - 1 - Pyrrolidinecarboxylic Acid, (4 - Nitrophenyl) Methyl Ester. |
| Shipping | (2S - Cis)-2-[(Dimethylamino)Carbonyl]-4-Mercapto-1-Pyrrolidinecarboxylic Acid, (4 - Nitrophenyl) Methyl Ester is shipped in accordance with chemical safety regulations, in sealed, appropriate containers to prevent spills and ensure safe transit. |
| Storage | (2S - Cis)-2 - [(Dimethylamino)Carbonyl]-4 - Mercapto - 1 - Pyrrolidinecarboxylic Acid, (4 - Nitrophenyl) Methyl Ester should be stored in a cool, dry place away from heat and ignition sources. Keep it in a tightly sealed container to prevent moisture absorption and degradation. Store in a location with good ventilation to avoid vapor buildup. |
|
Incorporation of a pre-activated 4-nitrophenyl methyl ester eliminates the need for carbodiimide coupling additives during solid-phase elongation. The title compound is dissolved in anhydrous DMF to a concentration of 0.12–0.18 M and introduced to the resin at 1.3–1.8 molar equivalents relative to the free amine. Agitation is maintained at 55–65 rpm under a positive argon sweep at 22±2 °C for 90–150 min. Completion is monitored by the Kaiser test; a negative result within the first cycle dictates an immediate double-couple before proceeding. The free 4-mercapto substituent is particularly susceptible to air oxidation, generating disulfide dimers that precipitate as a gel-like coating on resin beads and reduce the effective amine concentration by 8–15% in subsequent deprotection steps. To mitigate this, the reagent bottle headspace is blanketed with nitrogen during automated dispensing, and the synthesis vessel jacket is precooled to 5 °C when coupling sequences exceed six amino acids. The orthogonally reactive 4-nitrophenyl ester withstands the standard 20% piperidine/DMF Fmoc-removal cycle with less than 2% premature ester cleavage, as verified by LC-MS monitoring of the filtrate. Final resin cleavage with a cocktail of TFA/TIS/H₂O (95:2.5:2.5 v/v) over 3 h releases the crude peptide incorporating the 2-[(dimethylamino)carbonyl]-4-mercaptoproline moiety, which is precipitated in cold diethyl ether. Purification employs preparative C18 RP-HPLC with a 0.1% TFA/acetonitrile gradient; the target fraction is lyophilized directly. The resulting peptide, such as a macrocyclic inhibitor of prostate-specific membrane antigen, must be characterized for free thiol content via Ellman’s assay before formulation. Residual 4-nitrobenzyl alcohol, a known leachable, is controlled below 0.15% (w/w) per ICH Q3C options for Class 2 solvents. The entire process scope aligns with ICH Q7 Section 7.3 for active pharmaceutical ingredient manufacturing; analytical release incorporates enantiomeric purity by chiral HPLC (≥99.0%), water content by Karl Fischer titration (≤0.5%), and elemental analysis for total nitrogen and sulfur within ±0.4% of theoretical values. What Chelation Geometry Does the 4-Mercapto Subunit Offer When Coordinating ⁹⁹ᵐTc Tricarbonyl Cores?The use of the title compound as a bifunctional chelator precursor exploits the thiolate donor for fac-[⁹⁹ᵐTc(H₂O)₃(CO)₃]⁺ coordination while the active ester arm attaches to a tumour-targeting peptide vector. The synthesis is performed under cGMP conditions for radiopharmaceutical preparation as delineated in 21 CFR 212 and USP <823>. The lyophilized peptide-active ester conjugate ( 1.0 µmol ) is reconstituted in PBS, pH 7.4, and added to freshly reduced [⁹⁹ᵐTc(H₂O)₃(CO)₃]⁺ eluate from a commercial Isolink® kit. The mixture is heated at 100 °C for 20 min in a sealed, argon-purged vial; the pH is maintained between 7.0 and 7.8 to prevent hydrolysis of the ester residue that could release free 4-nitrobenzyl alcohol into the injectable. Radiochemical purity is assessed by ITLC-SG in 0.9% saline and by RP-HPLC with a radioactive detector; the target complex typically exceeds 95% radiolabelling yield at specific activities of 20–35 MBq/nmol. The resulting technetium-99m coordination complex adopts a distorted octahedral geometry wherein the thiolate occupies one equatorial position trans to one carbonyl, according to comparative IR spectroscopy of the tricarbonyl stretching region. Stability in human serum at 37 °C is recorded over 24 h; less than 3% free pertechnetate or ⁹⁹ᵐTc-cysteine transchelation product is detected. The final drug product is a multi-dose injection intended for metastatic prostate cancer imaging by SPECT/CT, with a shelf life of 6 h post-reconstitution. Release specifications include sterility testing per USP <71>, bacterial endotoxins per USP <85> (limit ≤175 EU/V), and residual solvent analysis for 4-nitrobenzyl alcohol by headspace GC-MS set to a reporting threshold of 50 ppm. Where the active ester is used as a heterobifunctional linker for antibody-drug conjugates, site-selective acylation of surface-exposed lysine ε-amines competes with hydrolysis. The monoclonal antibody is buffer-exchanged into 50 mM sodium borate, pH 8.5, containing 5% (v/v) DMA as co-solvent to maintain solubility of the linker. The title compound is added at 2.0–3.5 molar equivalents per antibody from a concentrated stock in anhydrous DMA. The reaction proceeds at 20 °C for 60 min with gentle end-over-end mixing. The unconjugated linker and 4-nitrobenzyl alcohol byproduct are removed by tangential flow filtration over a 30 kDa regenerated cellulose membrane with 12 diavolumes of formulation buffer. The resulting antibody-linker intermediate carries 3.2–4.8 free thiol groups per IgG molecule, as determined by Ellman’s assay and MALDI-TOF MS analysis of the reduced light chain. A maleimide-functionalized cytotoxic payload—typically monomethyl auristatin E or maytansinoid DM1—is subsequently added at 1.2× molar excess over free thiol content in PBS, pH 6.8, containing 1 mM EDTA to chelate trace metals that catalyse thiol oxidation. Conjugation proceeds for 45 min at 25 °C. The final ADC is purified by preparative size-exclusion chromatography (Superdex 200 Increase 10/300 GL column) to achieve a drug-to-antibody ratio of 3.5–4.2 and monomer purity above 98% by analytical SEC-HPLC. Compliance with FDA Guidance for Industry: Antibody-Drug Conjugates and ICH Q5A (R2) on viral safety requires that all critical raw materials, including the linker, are tested for bioburden and endotoxins before conjugation. A forced deconjugation study at 40 °C/75% RH over 28 days quantifies the retardant effect of the 4-mercapto substitution on retro-Michael elimination; published data for this specific linker-payload combination remain limited to proprietary development reports. Self-Assembling Monolayer Precursors on Evaporated Gold FilmsThe thiol group chemisorbs spontaneously onto clean polycrystalline gold surfaces to form a densely packed SAM with the ester-terminated pyrrolidine ring oriented away from the substrate. Gold-coated silicon wafers ( 200 nm Au on 10 nm Cr adhesion layer) are cleaned in piranha solution (Caution: corrosive), rinsed with copious ultrapure water, and dried under nitrogen before immersion in a 1.0 mM solution of the title compound in anhydrous ethanol. Assembly is conducted under argon at 25 °C for 18–24 h in the dark to prevent photodegradation of the nitroaromatic moiety. After incubation, the substrates are sonicated sequentially in ethanol and water to remove physisorbed multilayers and then blow-dried. Ellipsometric thickness measurements yield a thickness of 1.8–2.1 nm, consistent with a monolayer in which the 4-nitrophenyl methyl ester unit adopts a tilted orientation relative to the surface normal. Contact angle goniometry against water reveals an advancing angle of 68±3°, intermediate between that of an aromatic nitro-terminated SAM and an underivatized gold surface. The activated ester functionality remains accessible for on-surface amidation: exposure of the SAM to 0.5 mM amino-terminated poly(ethylene glycol) (Mw 2000 Da) in DMF at ambient temperature for 2 h produces a PEG brush that resists non-specific protein adsorption, reducing bovine serum albumin binding by 89% relative to bare gold in surface plasmon resonance assays. X-ray photoelectron spectroscopy of the S 2p region confirms a thiolate signal at 162.0 eV without oxidized sulfur at 167–170 eV, indicating intact Au–S bonds. These substrates serve as platforms for electrochemical DNA sensors; the film is processed further by reductive potential cycling in 0.5 M KCl to expose a secondary amine for covalent probe immobilization. Compliance with ISO/TS 21362:2018 on nanoparticle and film characterization is referenced for analytical methods; batch-to-batch variability in SAM thickness must remain within ±0.25 nm to ensure reproducible sensor response. Photoclick networks prepared by thiol-ene step-growth polymerization employ the 4-mercapto group as a latency-breaking chain-transfer site without the need for an external initiator fragment. The formulation combines a trifunctional norbornene-terminated prepolymer (Mn 2400 g/mol) with the title compound at a stoichiometric ratio of [norbornene]:[thiol] = 1:0.8 to maintain a slight excess of ene groups for post-cure functionalization. The active ester is dissolved in a minimum volume of DCM and blended into the viscous resin using a FlackTek SpeedMixer at 2000 rpm for 3 min under reduced pressure to eliminate bubbles. The mixture is cast into PTFE moulds and irradiated with 365 nm UV light at an intensity of 15 mW/cm² for 8 min under nitrogen. Real-time FTIR monitors the decay of the thiol absorbance at 2570 cm⁻¹; 92% conversion is achieved within the first 5 min. The resulting elastomeric film exhibits a glass transition temperature of −12 °C and a storage modulus of 1.4 MPa at 25 °C as determined by DMA in tension mode. Unexhausted 4-nitrophenyl ester moieties decorating the network serve as anchors for a subsequent amidation step with a fluorophore- or biotin-amine, enabling patterning of biomolecule adhesion. Tensile properties are measured per ASTM D638-14 (Type V specimen): ultimate tensile strength of 2.1±0.3 MPa and elongation at break of 210±25% are recorded after hydration in PBS for 24 h. Cytotoxicity testing against L929 fibroblasts in accordance with ISO 10993-5 demonstrates >85% viability when leachables are removed by serial ethanol extraction. For Class II medical device applications under FDA 510(k) pathways, batch release additionally includes quantification of residual 4-nitrobenzyl alcohol by GC-MS with a limit of ≤0.05 µg/mL in simulated physiological extract. When the Dimethylcarbamoyl Unit Directs Regioselectivity in a Cysteine Protease Inhibitor PharmacophoreThe dimethylcarbamoyl substituent at the 2-position of the pyrrolidine ring creates a hydrogen-bond acceptor network that positions the 4-mercapto group into the S1′ pocket of caspase-3. In a typical medicinal chemistry campaign, the title active ester is coupled to a tripeptide sequence (Asp-Glu-Val) anchored on 2-chlorotrityl chloride resin. The coupling is performed as described above, with a slight modification: 0.5 eq of Oxyma Pure is added to the active ester solution to scavenge any autocatalytically generated 4-nitrobenzyl alcohol that might re-acylate the growing chain. After cleavage and side-chain deprotection, the crude peptide is cyclized via on-resin thioester formation, exploiting the free 4-mercapto group. The macrocyclization proceeds at 1 mM concentration in 0.1 M NH₄HCO₃ buffer, pH 8.0, with 5 mM TCEP to maintain a reducing environment. The cyclic inhibitor is isolated with 65% overall yield and tested in a fluorogenic kinetic assay using Ac-DEVD-AMC substrate. An IC₅₀ value of 48 nM is recorded; co-crystallization with recombinant human caspase-3 reveals a C–S distance of 3.4 Å between the thiolate and the active-site cysteine, corroborating the design hypothesis. Scale-up to 50 g batch size in a kilo-lab fume hood requires jacketed reactors with PTFE-lined charging lines, as the free thiol reacts with stainless steel 316L surfaces at temperatures above 30 °C, generating metal-thiolate complexes that are detectable by blue-green discolouration of the reaction mixture. The final API precursor is stored as a lyophilized powder at −20 °C under argon; any vial opened for longer than 45 min at ambient humidity shows a 3–5% rise in the disulfide dimer as quantified by UPLC. The process validation approach follows ICH Q11 on the development of chemical entities starting materials, with particular attention to the control of mutagenic impurities: the liberated 4-nitrobenzyl alcohol is a potential mutagenic structural alert and is purged to below the threshold of toxicological concern (1.5 µg/day) using multiple recrystallization steps.
In a surface-enhanced Raman scattering assay, the 4-nitrophenyl ring acts as an internal Raman tag while the thiol anchors the entire compound onto citrate-reduced 60 nm gold nanoparticles. The particles are first cleaned by centrifugation at 7000 g for 10 min and redispersed in 0.1 mM trisodium citrate. A 10 µM ethanolic solution of the active ester is added dropwise under sonication, achieving a final surface coverage of approximately 2.5×10⁴ molecules per particle, estimated by the depletion method and UV-Vis absorption at 320 nm. After 30 min of equilibration, the SERS spectrum under 633 nm He-Ne excitation shows the symmetric nitro stretch at 1338 cm⁻¹ with an enhancement factor on the order of 10⁶. When a primary amine-bearing analyte—such as a 10 nM solution of benzocaine—is introduced, the ester undergoes amidation directly on the SERS substrate, causing a reproducible decrease in the nitro band intensity of 0.12 ± 0.03 a.u. and the appearance of a new amide II band at 1548 cm⁻¹. The time-dependent spectral shift follows pseudo-first-order kinetics with a rate constant of 0.085 min⁻¹, enabling quantitative detection of amine-containing drugs in saliva simulant. Cross-reactivity with common biothiols (cysteine, glutathione) is suppressed by pre-blocking the gold surface with 0.01 mM 2-mercaptoethanol after the active ester deposition; this step does not displace the pre-bound SAM because the multidentate pyrrolidine framework affords a higher binding avidity. A field-portable Raman analyser with a 50 mW diode laser at 785 nm is used for on-site screening against doping substances at equestrian events, with results cross-validated by LC-MS/MS per ISO 17025. The analytical performance characteristics—repeatability (RSD ≤7%, n=12), intermediate precision, and limit of detection—are validated following EURACHEM guidelines; the LOD for benzocaine in artificial saliva is 18 ng/mL. Published data for this specific ester-ligand architecture on gold nanoshells is limited to a single exploratory communication; field deployment demands additional accelerated stability studies at 60 °C/75% RH to justify a 12-month shelf-life claim. |
Competitive (2S-Cis)-2-[(Dimethylamino)Carbonyl]-4-Mercapto-1-Pyrrolidinecarboxylic Acid, (4-Nitrophenyl) Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Ester Type | Cleavage Condition | Thiol Integrity (Ellman’s assay) | Epimerization at C2 (%) |
|---|---|---|---|
| 4‑Nitrobenzyl | Zn/NH₄OAc, t‑BuOH/H₂O, 25 °C, 2 h | 98% | <0.3 |
| Methyl | LiOH (1 eq), THF/H₂O, 0 °C, 1 h | 91% | 2.5 |
| Benzyl | H₂ (1 atm), 10% Pd/C, MeOH, 25 °C, 4 h | 78% (catalyst poisoning) | 1.1 |
| tert‑Butyl | TFA/CH₂Cl₂ 1:1, 25 °C, 1 h | 96% | <0.5 |
| Ester Type | Cleavage Condition | Thiol Integrity (Ellman’s assay) | Epimerization at C2 (%) |
|---|---|---|---|
| 4‑Nitrobenzyl | Zn/NH₄OAc, t‑BuOH/H₂O, 25 °C, 2 h | 98% | <0.3 |
| Methyl | LiOH (1 eq), THF/H₂O, 0 °C, 1 h | 91% | 2.5 |
| Benzyl | H₂ (1 atm), 10% Pd/C, MeOH, 25 °C, 4 h | 78% (catalyst poisoning) | 1.1 |
| tert‑Butyl | TFA/CH₂Cl₂ 1:1, 25 °C, 1 h | 96% | <0.5 |